Articles

The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker Consortium

Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden
Department of Pathology, Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
Institute of Pathology, University of Würzburg, Germany
Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA
Department of Pathology, Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary, University of London, UK
Hematopathology Section, Department of Pathology, Hospital Clinic, IDIBAPS, University of Barcelona, Spain
Department of Pathology and Inserm U955, Hôpital Henri Mondor, University Paris-Est Créteil, Franc
Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary, University of London, UK
Academic Medical Center, Department of Hematology, Amsterdam, The Netherlands
Academic Medical Center, Department of Hematology, Amsterdam, The Netherlands
Université Paris-Descartes and AP-HP, Hôtel-Dieu, Paris, France
Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary, University of London, UK
Department of Pathology, Hospital Universitario Marqués de Valdecilla/IFIMAV, Santander, Spain
Department of Clinical Pathology, RobertBosch-Krankenhaus, and Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany
Department of Hematology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
Hospices Civils de Lyon and Université Claude Bernard Lyon-1, UMR CNRS 5239, Lyon, France
Department of Pathology and Medical Oncology, British Columbia Cancer Agency, University of British Columbia, Vancouver, Canada
Department of Pathology, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Germany
Department of Medicine, Division of Hematology, Karolinska Institutet, Stockholm, Sweden
Department of Pathology and Medical Oncology, British Columbia Cancer Agency, University of British Columbia, Vancouver, Canada
Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA
Vol. 99 No. 4 (2014): April, 2014 https://doi.org/10.3324/haematol.2013.095257